Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Franco-German startup Doctolib gets unicorn status with 150 million-euro fundraising

Published 03/19/2019, 06:30 PM
Updated 03/19/2019, 06:35 PM
© Reuters. FILE PHOTO:  Stanislas Niox-Chateau, Co-Founder & CEO of  Doctolib, poses at the entrance of the company's headquarters in Paris

PARIS (Reuters) - Franco-German start-up Doctolib, an online booking platform for doctors, has raised 150 million euros from a pool of investors led by U.S. venture capital giant General Atlantic, it said on Tuesday.

The fundraising brings the company's valuation to over 1 billion euros ($1.14 billion), it said in a statement, taking it to the coveted club of so-called "unicorns" -- or startups that valued above that threshold.

General Atlantic, which has $31 billion in assets under management, which has notably invested in China's biggest e-commerce company Alibaba (NYSE:BABA) and flat-sharing app Airbnb, made health one of the key fields in which to invest.

Doctolib's existing investors, which include investment firm Eurazeo (PA:EURA), France's state-owned investment bank Bpifrance and venture funds Kernel and Accel, also took part in the round, the company's fifth.

The six-year-old group, based in Paris and Berlin, has not yet reached break even and does not disclose its financial figures.

It says it receives about 30 million online visits from patients every month and works with over 75,000 physicians, who subscribe to its online service for 109 euros a month.

Doctolib's software aims to cut the so-called "no show" rate, or the number of people who do not turn up for their medical appointments.

It also seeks to ease doctors' day-to-day communication with patients via remote visits by computer and the sharing of health documents on its platform.

Doctolib intends to spend the new funds to double its staff to 1,500 in the next three years. It also aims to expand out these two markets internationally but declined to provide any target. ($1 = 0.8810 euros)

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.